Y mAbs TherapeuticsEigentümerstruktur
| Preis (2025-09-16) | 52W Hoch | 52W Tief |
| 8.61 USD | 8,61 USD | 4,16 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 8,6 USD | 7 | 1 | 0 | 1 | 1 |
| #Shares | Short [%] | Short Ratio |
| 45.438.400 | 4,83 | 1 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Y mAbs Therapeutics
Mitarbeiter 104
Handelsplatz NASDAQ
Ticker Symbol YMAB
IPO Datum 2018-09-21
Adresse 202 Carnegie Center, Princeton, NJ, United States, 08540
Webseite https://www.ymabs.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Michael Rossi | CEO, President & Director |
| 2 | Mr. Thomas Gad | Founder, Chief Business Officer & Vice Chairman |
| 3 | Mr. Peter P. Pfreundschuh CPA | Executive VP, CFO & Treasurer |
| 4 | Mr. Joris Wiel Jan Wilms | Senior VP & COO |
| 5 | Dr. Torben Lund-Hansen M.Sc., Ph.D. | Senior VP & CTO |
| 6 | Ms. Courtney Dugan | VP & Head of Investor Relations |
| 7 | Mr. John W. LaRocca Esq. | Senior VP, General Counsel, Secretary & Chief Legal Officer |
| 8 | Dr. Norman D. LaFrance FACNP, FACP, M.D. | Chief Development Officer & Chief Medical Officer |
| 9 | Mr. Doug Gentilcore | Senior VP & Head of DANYELZA Business Unit |
| 10 | Ms. Natalie Tucker | Senior VP & Radiopharmaceutical Business Unit Head |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Paradigm Biocapital Advisors LP | 0,00% | 0,00 Mio. USD |
| 2 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 3 | Caligan Partners LP | 0,00% | 0,00 Mio. USD |
| 4 | Sofinnova Ventures | 0,00% | 0,00 Mio. USD |
| 5 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 6 | Polar Capital Holdings PLC | 0,00% | 0,00 Mio. USD |
| 7 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 8 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 9 | BOOTHBAY FUND MANAGEMENT, LLC | 0,00% | 0,00 Mio. USD |
| 10 | D. E. Shaw & Co LP | 0,00% | 0,00 Mio. USD |
| 11 | Dimensional Fund Advisors, Inc. | 0,00% | 0,00 Mio. USD |
| 12 | Nantahala Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 13 | Soleus Capital Management, L.P. | 0,00% | 0,00 Mio. USD |
| 14 | Northern Trust Corp | 0,00% | 0,00 Mio. USD |
| 15 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |
| 16 | Stonepine Capital Management Llc | 0,00% | 0,00 Mio. USD |
| 17 | Charles Schwab Investment Management Inc | 0,00% | 0,00 Mio. USD |
| 18 | Bank of America Corp | 0,00% | 0,00 Mio. USD |
| 19 | AQR Capital Management LLC | 0,00% | 0,00 Mio. USD |
| 20 | UBS Group AG | 0,00% | 0,00 Mio. USD |